Results 211 to 220 of about 69,782 (261)

[Recent Advances in Medical Treatment of Malignant Pleural Mesothelioma]. [PDF]

Zhongguo Fei Ai Za Zhi
Yang J, Kong F.
europepmc   +1 more source

Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma. [PDF]

Cell Death Dis
Cakiroglu E, Eris S, Oz O, Karakülah G, Senturk S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Malignant pleural mesothelioma

BMJ Case Reports
Malignant pleural mesothelioma is a rare and aggressive tumour of the pleura, commonly linked to asbestos exposure. However, its diagnosis is challenging, especially without known exposure. We present the case of a woman in her early 70s with no history of asbestos exposure, who presented with progressive breathlessness and left-sided chest pain ...
Pragati Rao D, Sruthy Vijayan, Shashidhar S Vananjakar, Prasanna Kumar T   +3 more
semanticscholar   +4 more sources

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2021
Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto   +2 more
exaly   +2 more sources

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

Nature Genetics, 2023
Malignant pleural mesothelioma (MPM) is an aggressive cancer with rising incidence and challenging clinical management. Through a large series of whole-genome sequencing data, integrated with transcriptomic and epigenomic data using multiomics factor ...
Lise Mangiante, Nicolas Alcala, Abel Gonzalez-Perez   +2 more
exaly   +2 more sources

Immunotherapy approaches for malignant pleural mesothelioma

Nature Reviews Clinical Oncology, 2022
Dean A Fennell
exaly   +2 more sources

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Journal of Clinical Oncology, 2003
Salih Emri
exaly   +2 more sources

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline

Journal of Clinical Oncology, 2018
Hedy L Kindler, Nofisat Ismaila, Raphael Bueno   +2 more
exaly   +2 more sources

Malignant Pleural Mesothelioma

Current Oncology Reports, 2011
Malignant pleural mesothelioma (MPM) is a relatively rare thoracic malignancy accounting for about 2000-3000 new cases per year. This cancer has been increasing in incidence and is strongly associated with asbestos exposure. Also, it is characterized by insidious growth and clinical presentation at an advanced stage of disease.
Siva, Raja, Sudish C, Murthy, David P, Mason   +2 more
openaire   +3 more sources